IRELAND – Medtronic announced leadership changes in a number of key business segments, including the appointment of Que Dallara to lead its diabetes unit, Mike Marinaro to lead its surgical robotics division, and Kweli Thompson to lead cardiac rhythm management.

The future of medical technology requires strong leadership in data science, artificial intelligence and robotics, all of which make these three operating unit president roles some of the most important and dynamic leadership opportunities in our industry,” said CEO Geoff Martha.

Dallara is set to join Medtronic on May 2, succeeding Sean Salmon, who is currently president of the cardiovascular portfolio and diabetes unit but will now focus solely on the cardiovascular portfolio.

Dallara will leave Honeywell, where she was previously CEO of Honeywell Connected Enterprise and chief commercial officer.

She has also worked as a general manager and in strategy at TE Connectivity and Microsoft.

Marinaro has been with Medtronic for over 20 years, most recently leading the cardiac rhythm management operating unit. He will report to Bob White, EVP and President of the Medical Surgical Portfolio.

Sean Salmon, EVP and president of Medtronic’s cardiovascular portfolio and diabetes unit, will focus solely on leading the cardiovascular portfolio while assisting Dallara in her transition.

Marinaro takes over for Megan Rosengarten, who is “taking a planned six-month sabbatical to spend more time with her family with the full support of Medtronic.”

For four years, Rosengarten oversaw surgical robotics, which included the company’s Hugo system.

Thompson will take over the cardiac rhythm management unit, reporting to Salmon. Thompson previously held the positions of vice president and general manager of the cardiac resynchronization and defibrillation solutions businesses.

According to Medtronic, he has two decades of experience in business development, clinical research, product marketing, and general management.

Medtronic has been on a hiring binge in recent months. Last October, it hired gastroenterologist Austin Chiang, M.D., who has a sizable TikTok following, to fill the newly created position of chief medical officer of its gastrointestinal business.

Only a few weeks later, the company named four new executives, including the presidents of two of its business operating units—cranial and spinal technologies and pelvic health—as well as new heads of global strategy and global digital innovation.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE